Global Tuberculosis Report 2024 (World Health Organization, 2024).
van Doorn, C. L. R. et al. Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment. EBioMedicine 82, 104173 (2022).
Google Scholar
Helaine, S., Conlon, B. P., Davis, K. M. & Russell, D. G. Host stress drives tolerance and persistence: the bane of anti-microbial therapeutics. Cell Host Microbe 32, 852–862 (2024).
Google Scholar
Ramakrishnan, L. Revisiting the role of the granuloma in tuberculosis. Nat. Rev. Immunol. 12, 352–366 (2012).
Google Scholar
Caño-Muñiz, S., Anthony, R., Niemann, S. & Alffenaar, J. C. New approaches and therapeutic options for Mycobacterium tuberculosis in a dormant state. Clin. Microbiol. Rev. 31, e00060–17 (2018).
van Rie, A. et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N. Engl. J. Med. 341, 1174–1179 (1999).
Google Scholar
Verver, S. et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am. J. Respir. Crit. Care Med. 171, 1430–1435 (2005).
Google Scholar
Youn, H. M. et al. Risk factors associated with tuberculosis recurrence in South Korea determined using a nationwide cohort study. PLoS ONE 17, e0268290 (2022).
Google Scholar
Abrahams, K. A. et al. DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid. Nat. Commun. 14, 3828 (2023).
Google Scholar
Wallis, R. S., O’Garra, A., Sher, A. & Wack, A. Host-directed immunotherapy of viral and bacterial infections: past, present and future. Nat. Rev. Immunol. 23, 121–133 (2023).
Google Scholar
Vekemans, J. et al. Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: key considerations from World Health Organization consultations. Vaccine 38, 135–142 (2020).
Google Scholar
Li, B. et al. Photothermal therapy of tuberculosis using targeting pre-activated macrophage membrane-coated nanoparticles. Nat. Nanotechnol. 19, 834–845 (2024).
Google Scholar
Wang, H. et al. NIR-II AIE luminogen-based erythrocyte-like nanoparticles with granuloma-targeting and self-oxygenation characteristics for combined phototherapy of tuberculosis. Adv. Mater. 36, 2406143 (2024).
Google Scholar
Wang, W. et al. Biosafety materials for tuberculosis treatment. Biosaf. Health. 4, 258–268 (2022).
Google Scholar
Suman, S. K., Chandrasekaran, N. & Priya Doss, C. G. Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments. Clin. Microbiol. Rev. 36, e0008823 (2023).
Google Scholar
Wang, L. et al. Single-cell RNA-sequencing reveals heterogeneity and intercellular crosstalk in human tuberculosis lung. J. Infect. 87, 373–384 (2023).
Google Scholar
Gideon, H. P. et al. Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control. Immunity 55, 827–846.e810 (2022).
Google Scholar
Cliff, J. M. et al. Excessive cytolytic responses predict tuberculosis relapse after apparently successful treatment. J. Infect. Dis. 213, 485–495 (2016).
Google Scholar
Chai, Q., Wang, L., Liu, C. H. & Ge, B. New insights into the evasion of host innate immunity by Mycobacterium tuberculosis. Cell. Mol. Immunol. 17, 901–913 (2020).
Google Scholar
McCaffrey, E. F. et al. The immunoregulatory landscape of human tuberculosis granulomas. Nat. Immunol. 23, 318–329 (2022).
Google Scholar
Nagai, Y. et al. Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood 99, 1699–1705 (2002).
Google Scholar
Zhuang, L., Yang, L., Li, L., Ye, Z. & Gong, W. Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention. MedComm 5, e419 (2024).
Google Scholar
Hwang, A. A. et al. pH-responsive isoniazid-loaded nanoparticles markedly improve tuberculosis treatment in mice. Small 11, 5066–5078 (2015).
Google Scholar
Tiberi, S. et al. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. Lancet Infect. Dis. 18, 183–198 (2018).
Google Scholar
Piksa, M. et al. The role of the light source in antimicrobial photodynamic therapy. Chem. Soc. Rev. 52, 1697–1722 (2023).
Google Scholar
Son, S. et al. Multifunctional sonosensitizers in sonodynamic cancer therapy. Chem. Soc. Rev. 49, 3244–3261 (2020).
Google Scholar
Ouyang, J. et al. Ultrasound mediated therapy: Recent progress and challenges in nanoscience. Nano Today 35, 100949 (2020).
Google Scholar
Li, Y. et al. Nanosensitizer-mediated augmentation of sonodynamic therapy efficacy and antitumor immunity. Nat. Commun. 14, 6973 (2023).
Google Scholar
Li, J. et al. Precision cancer sono-immunotherapy using deep-tissue activatable semiconducting polymer immunomodulatory nanoparticles. Nat. Commun. 13, 4032 (2022).
Google Scholar
Li, J. & Pu, K. Development of organic semiconducting materials for deep-tissue optical imaging, phototherapy and photoactivation. Chem. Soc. Rev. 48, 38–71 (2019).
Google Scholar
Pu, K. et al. Semiconducting polymer nanoparticles as photoacoustic molecular imaging probes in living mice. Nat. Nanotechnol. 9, 233–239 (2014).
Google Scholar
Tang, D. et al. Self-sacrificially degradable pseudo-semiconducting polymer nanoparticles that integrate NIR-II fluorescence bioimaging, photodynamic immunotherapy, and photo-activated chemotherapy. Adv. Mater. 34, e2203820 (2022).
Google Scholar
Li, W., Liang, M., Qi, J. & Ding, D. Semiconducting polymers for cancer immunotherapy. Macromol. Rapid Commun. 44, e2300496 (2023).
Google Scholar
Xu, C. et al. Nanoparticles with ultrasound-induced afterglow luminescence for tumour-specific theranostics. Nat. Biomed. Eng. 7, 298–312 (2023).
Google Scholar
He, S. et al. A semiconducting iron-chelating nano-immunomodulator for specific and sensitized sono-metallo-immunotherapy of cancer. Angew. Chem. Int. Ed. Engl. 62, e202310178 (2023).
Google Scholar
Li, F. et al. Organic semiconducting sono-metallo-detonated immunobombs for ultrasensitized domestication of immunosuppressive cells. Nano Lett. 24, 7340–7349 (2024).
Google Scholar
Sparks, I. L. et al. Lipoarabinomannan mediates localized cell wall integrity during division in mycobacteria. Nat. Commun. 15, 2191 (2024).
Google Scholar
Kang, P. B. et al. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp. Med. 202, 987–999 (2005).
Google Scholar
Behr, M. A. B. C. G. different strains, different vaccines?. The Lancet Infect. Dis. 2, 86–92 (2002).
Google Scholar
Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783–801 (2006).
Google Scholar
Narayan, R. et al. Immunomodulation by imiquimod in patients with high-risk primary melanoma. J. Investig. Dermatol. 132, 163–169 (2012).
Google Scholar
Wang, Y. et al. Small-molecule modulators of toll-like receptors. Acc. Chem. Res. 53, 1046–1055 (2020).
Google Scholar
West, A. P. et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 472, 476–480 (2011).
Google Scholar
Panda, S. et al. Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection. Nat. Commun. 15, 765 (2024).
Google Scholar
Musvosvi, M. et al. T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection. Nat. Med. 29, 258–269 (2023).
Google Scholar
Liang, J. et al. Engineering versatile nanomedicines for ultrasonic tumor immunotherapy. Adv. Sci. 11, e2305392 (2024).
Google Scholar
Rong, Z., Ertürk, A., Tang, Y. & Mai, H. Tissue clearing and its application in nanoparticle development. Small 21, 2410032 (2025).
Google Scholar
Liu, T. et al. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation. Sci. Rep. 6, 39473 (2016).
Google Scholar
Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S. & Bartenschlager, R. Host-directed therapies for bacterial and viral infections. Nat. Rev. Drug Discov. 17, 35–56 (2018).
Google Scholar
Hermans, S. M. et al. High rates of recurrent tuberculosis disease: a population-level cohort study. Clin. Infect. Dis. 72, 1919–1926 (2021).
Google Scholar
Panjabi, R., Comstock, G. W. & Golub, J. E. Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int. J. Tuberc. Lung Dis. 11, 828–837 (2007).
Google Scholar
Lambert, M. L. et al. Recurrence in tuberculosis: relapse or reinfection? The Lancet Infect. Dis. 3, 282–287 (2003).
Google Scholar
Sterling, T. R. et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N. Engl. J. Med. 365, 2155–2166 (2011).
Google Scholar
Schenkel, J. M. & Masopust, D. Tissue-resident memory T cells. Immunity 41, 886–897 (2014).
Google Scholar
Barnes, P. F. & Cave, M. D. Molecular epidemiology of tuberculosis. N. Engl. J. Med. 349, 1149–1156 (2003).
Google Scholar
Chiang, C. Y. & Riley, L. W. Exogenous reinfection in tuberculosis. The Lancet Infect. Dis. 5, 629–636 (2005).
Google Scholar
Wu, M. et al. Innervation of nociceptor neurons in the spleen promotes germinal center responses and humoral immunity. Cell 187, 2935–2951.e19 (2024).
Google Scholar
Lyashchenko, K. P., Vordermeier, H. M. & Waters, W. R. Memory B cells and tuberculosis. Vet. Immunol. Immunopathol. 221, 110016 (2020).
Google Scholar
Hu, Z. et al. Extracellular vesicle-inspired therapeutic strategies for the COVID-19. Adv. Healthc. Mater. 13, e2402103 (2024).
Google Scholar
Wang, W. et al. Antibiotic-loaded lactoferrin nanoparticles as a platform for enhanced infection therapy through targeted elimination of intracellular bacteria. Asian J. Pharm. Sci. 19, 100926 (2024).
Ouimet, M. et al. Mycobacterium tuberculosis induces the miR-33 locus to reprogram autophagy and host lipid metabolism. Nat. Immunol. 17, 677–686 (2016).
Google Scholar
Wang, W. et al. Ultrastable in-situ silver nanoparticle dressing for effective prevention and treatment of wound infection in emergency. Eng. Regener. 5, 111–123 (2024).
Google Scholar
date: 2026-02-10 19:56:00
Worth a look